Gilead Sciences and Pharmasset Incorporated - symbol VRUS - have signed a definitive agreement under which Gilead will acquire Pharmasset for $137 per share in cash

Tags: VRUS EDGR AEN Nasdaq:VRUS Nasdaq:EDGR Amex:AEN